Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 4 Carcinoma, Hepatocellular 2 Skin Neoplasms 1 Nervous System Diseases 1 Melanoma 1 Hepatitis 1 Colitis 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

XENP 1595 2 Oncolytic Virotherapy 2 Cognitive Behavioral Therapy 2 Cancer Vaccines 2 Adjuvants, Immunologic 2 pembrolizumab 1 pamiparib 1 interferon gamma-1b 1 glutathione pegylated liposomal doxorubicin 1 Trastuzumab 1 Thioctic Acid 1 Telemedicine 1 Radiation 1 Plasma Exchange 1 Mycophenolic Acid 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Interferon-gamma 1 Immunotherapy 1 Health Information Exchange 1 Clinical Laboratory Techniques 1 COVID-19 Vaccines 1 Blood Specimen Collection 1 Azathioprine 1 Antibodies, Monoclonal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nervous System Diseases × Azathioprine × Clear all

NCT03490539 2021-02-03

PROMISE-MG

Duke University

Autoimmune Diseases, Myasthenia Gravis, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡